Advertisement
<< Back To Article
HIV Drug Giant Gilead Acquires Pharmasset, a Hep C Drug Development Leader

Write a Comment

I have read and agree to the terms and conditions in the Posting Rules*

2 Comments

Brian

And now they kill joint trial with derisive campaign to not go on with Phase 3 and admit they need another drug to clear people not just PS/GS-7977-Gilead seemed to start out a great company and has turned into the exact type of co. ACT UP would have protested with quad pill pricing and now killing trials that will kill people due to them wanting to sub their drug for BMS drug but theirs is phase 1 and so now they delay and obfuscate truth by offering type 2 and 3 mono-treatment Ribavarsick?ugh

September 2, 2012 Beantown

Brian

I am happy connected co. can streamline and get this approved but with their history of pricing I expect it will now be 50k for 12 wks. of medicine-and at that price one has to wonder if this should not have seen some FTC scrutiny? America, land of the monopolies. Gilead has many good meds-they now have the only one that can save my life-please add trials for those connected who can least handle interferon-you need to step up humanitarian business and step back profit business- 4 million of us.

November 21, 2011 Boston

Advertisement

Hot topics


POZ uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy

Manage

POZ uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.